The aim of the present study was to evaluate the possible correlation between urinary albumin excretion (UAE), marker of endothelial dysfunction, and C-reactive protein (CRP), marker of chronic in¯ammation of the arterial wall, in overweight and obese premenopausal women. METHODS: CRP levels and UAE rate were measured in 103 overweight (BMI 25.0 ± 29.9 Kgam 2 ) and obese (BMI ! 30.0 Kgam 2 ) premenopausal women, aged 18 ± 45 years. Other measurements included central fat accumulation, as evaluated by waist circumference, insulin resistance, as calculated by homeostasis model assessment (HOMA IR ), systolic and diastolic blood pressure, and fasting plasma levels of glucose, insulin, and lipids. RESULTS: UAE was positively correlated with BMI (P`0.01), waist circumference (P`0.00l), diastolic blood pressure (P`0.01), triglyceride (P`0.01), HOMA IR (P`0.05), and CRP levels (P`0.05), and negatively associated with HDL-cholesterol (P`0.001). After multivariate analysis, diastolic blood pressure, HDL-cholesterol, and CRP levels maintained their signi®cant correlation with UAE (P`0.05, P`0.01, and P`0.01, respectively). Lastly, we observed a gradual increase in CRP plasma levels across the quartiles in which the whole population was divided according to UAE levels (F: 5.67, P 0.001 for linear trend). CONCLUSION: Our study shows a strong relationship between UAE rate and CRP concentrations, irrespective of age and other anthropometric and metabolic variables. On this basis, it can be argued that in¯ammation of the arterial wall, as indicated by higher CRP plasma levels, and endothelial dysfunction, as shown by higher UAE rate, might represent simultaneous phenomena in the development of atherosclerosis in overweight and obese premenopausal women.
INTRODUCTION: Hypertension, hyperlipemia, smoking, and hyperinsulinaemia are well known risk factors in the progression of atherosclerosis. Newer risk factors, such as hyperandrogenism or DHEAS and DHEA [DHEA(S)] levels have also been recently suggested, although the direct evidence that hyperinsulinaemia or DHEA(S) per se are directly involved has been con¯icting. We investigate the cross-sectional association of early carotid atherosclerosis, measured as intima-media thickness (IMT), with hyperinsulinaemia, and low circulating DHEA(S) levels in 17 normotensive severe obese premenopausal women and 10 normal-weight age-matched subjects. METHODS: Oral glucose tolerance test (OGTT), adrenal secretion, carotid diameter (CD), and left ventricular mass index (LVMi) were determined. RESULTS: Impaired glucose tolerance was present in 29% of the obese patients. DHEA(S) levels (P`0.001) were lower and negatively correlated with simulated insulin (r70.7; P`0.01), in spite of normal values of other androgens and increased plasma cortisol and urinary free cortisol were found in 53% of the obese patients, with normal dexamethasone suppression test. No differences were observed in systolic and diastolic blood pressure, heart rate, fasting triglycerides, or total cholesterol between the groups. CD, IMT, and LVMi were higher in obese women than in controls (P`0.05); using simple regression analysis, we found that CD was also positively correlated with BMI (r 0.5; P`0.05) and fasting insulin (r 0.6; P`0.05); a weak positive correlation was present between IMT and LVMi (r 0.6; P`0.05), while a strong negative correlation was present between IMT and DHEA(S) (r 0.9; P`0.01). The multiple regression analysis, using insulin, BMI, and DHEA(S) as covariates, showed insulin (P`0.01) and DHEA(S) (P`0.001) to be the most powerful predictors for CD and IMT, respectively. CONCLUSION: In normotensive severe obese premenopausal women without hyperandrogenism, hyperinsulinaemia and low DHEA(S) as early carotid atherosclerosis can be detected in absence of other covariated risk factors for cardiovascular disease, suggesting their independent role in atherosclerosis progression.
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Left ventricular hypertrophy regression: role of weight loss and insulin changes in obese normotensive subjects Polycystic ovary syndrome (PCOS) is associated with insulin resistance, glucose intolerance, dyslipidemia and atherosclerosis, a similar risk pro®le as in visceral obesity. The etiology is unknown. In order to study possible primary defects in omental adipose tissue from subjects with PCOS, we investigated visceral fat cells of 10 young non-obese PCOS women with normal metabolic pro®le, except slightly decreased insulin sensitivity and normal body fat distribution according to computerized tomography. METHODS: Lipolysis was measured in isolated fat cells by standard procedures. Protein was isolated from omental adipose tissue and separated by SDS-PAGE. Speci®c proteins were detected by Western blot. Speci®c lipolytic enzyme activity towards hormone sensitive lipase (HSL) was determined. RESULTS: In comparison to 13 control women, inhibition of lipolysis through insulin receptors and G i receptors was normal but stimulation of lipolysis through all three beta-adrenergic receptor subtypes was two-fold increased in PCOS due to enhanced ability of cyclic AMP to activate lipolysis. Examination of the lipolytic pathway demonstrated that PCOS cells display several differences at the protein level compared to control cells. The short form of HSL, which is an enzymatically inactive splice variant, was highly expressed in control cells while PCOS cells showed a markedly reduced level. The expression of the catalytic subunit of protein kinase A (PKA) was increased in PCOS cells. Furthermore, detailed studies on the regulatory PKA subunits demonstrated that while Reg IIb was lowered, Regla levels were signi®cantly increased in PCOS cells. This transition in regulatory subunits has been shown to enhance lipolytic activity in a transgenic animal models. All lipase activity in visceral fat cells could be attributed to hormone sensitive lipase. CONCLUSION: Young non-obese PCOS women with no apparent metabolic abnormality except slightly decreased insulin sensitivity have a marked increase in the lipolytic function of visceral fat cells due to a superef®cient HSL-PKA complex. This in turn would increase fatty acid delivery to the liver and be an early and primary defect in the.
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Greater increase in adipose tissue blood¯ow after oral compared with intravenous glucose Adipose tissue blood¯ow (ATBF) increases after meal intake and failure to regulate ATBF in the postprandial period may be a feature of insulin resistance and obesity. The factors that regulate ATBF in the postprandial period are not well understood, but insulin action is a potential mediator. The aim of this study was to compare ATBF in subcutaneous abdominal adipose tissue after oral glucose or intravenous glucoseainsulin administration. The aim was to achieve similar peripheral glucose and insulin concentrations on the two visits. 15 healthy subjects (8 male) participated in the study after an overnight fast. Their mean age was 35.3 years (23 ± 52) and mean BMI was 23.8 kgam 2 (19 ± 30). On the ®rst visit, ATBF was measured by 133 Xe washout, before and after 75 g oral glucose. On the second, similar concentrations of insulin and glucose in plasma were achieved by dynamic i.v. infusions.
BA Fielding
There was signi®cant heterogeneity in ATBF response between subjects on both days (P`0.001). The mean peak ATBF was 7.9 AE 1.6 and 4.5 AE 0.8 mlaminal00 g tissue after oral and i.v. glucose respectively (P`0.05). Nine out of ®fteen subjects exhibited an increase in ATBF in response to oral glucose that was greater than 50% and in the top tertile the increase was 212 AE 49%. The respective value after i.v. glucose in the same ®ve subjects was 93 AE 44%. There was a signi®cant correlation between peak ATBF in response to the two treatments (Spearman's r s 0.87, P`0.001). For both regimens, peak ATBF was signi®cantly correlated with baseline ATBF (r s 0.60, P`0.05 and r s 0.72, P`0.05 for oral and i.v. glucose respectively). Peak ATBF was negatively correlated with BMI (r s 70.52, P`0.05 for both treatments).
The results show an ATBF response can be elicited either by oral or by i.v. glucose administration, but the effect is greater after oral ingestion. This suggests that factors in addition to an increasing postprandial insulin concentration are associated with modulation of postprandial ATBF. Studies such as this will increase the understanding of the regulation of ATBF in healthy subjects and the implications of dysregulation of ATBF in obesity.
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Expression of endothelin-system genes and secretion of endothelin-1 by human adipocytes
S Engeli
1 , J Janke Recent studies have demonstrated that the potent vasoconstrictor peptide endothelin-1 inhibits adipogenesis and activity of lipoprotein lipase activity in rat and human adipocytes via endothelin receptor type A receptors. Furthermore, endothelin-1 plasma levels have been reported to be higher in obese individuals. At present, no study has investigated the presence of endothelin system components in human adipose tissue. We studied the expression pattern of endothelin system genes in human adipose tissue, isolated adipocytes, and cultured preadipocytes by conventional RT-PCR (n 6 for each sample) and measured secretion of big-endothelin-1 into the culture medium of human primary cultured adipocytes by radioimmunoassay. We also measured the expression level of the endothelin-1 gene in lean and obese subjects by TaqMan-RT-PCR (n 30).
Expression of the genes for endothelin-1, type A and type B endothelin receptors, and the endothelin-1 regulating transcription factor GATA-2 were detected in human adipose tissue as well as in isolated adipocytes and preadipocytes. Radioimmunoassay studies revealed secretion of big-endothelin-1 by primary cultured human adipocytes into the culture medium. Endothelin-converting-enzyme, that liberates active endothelin-1 from its precursor big-endothelin-1, was not detected in adipose cells. Quantitative expression of the endothelin-1 gene was higher in obese normotensive subjects compared to lean normotensive and obese hypertensive subjects.
Our data point to a potential contribution of adipocytes to increased endothelin-1 plasma levels. Further studies must elucidate the regulation of big-endo-thelin-1 secretion by adipocytes and its possible contribution to adipose tissue physiology.
INTRODUCTION:
Obesity is a metabolic disease associated with immunological complications. It is known that TNF a, pluripotent cytokine secreted in abundance by adipocytes in obesity, stimulates the antioxidant response of manganese-containing superoxide dismutase (MnSOD). METHODS: Lipid pro®le and plasma (pl) and erythrocytes (e) activities of copperazinc superoxide dismutase (CuaZnSOD), MnSOD and glutathione peroxidase (GSHpx), and concentration of malondialdehyde (MDA) were examined in 29 premenopausal obese and 14 lean women (age 34 AE 7. The 677 C A T MTHFR mutation increases the folates requirements in humans. Low folates in turn lead to increased plasma homocysteine (HCY) levels, an independant cardiovascular risk factor. The aim of this study is to determine folate requirements, based on HCY plasma concentrations, in obese adolescents during weight reduction. 97 obese adolescents (BMI 36.1 AE 6.0 kgam 2 ) including 60 girls and 37 boys, aged 14.1 AE 1.5 yrs were included. 73 completed an inpatient interdisciplinary weight (Wt) reduction program during 6 to 12 months, 5 days per week. Wt reduction program included a modertate caloric restriction (720% of national RDAs) at the expense of sucrose and saturated fat, within a balanced diet which provided 400 mg of folate per day. Regular submaximal physical training was also included.
Folate intakes before Wt loss were assessed by mean of adapted food frequency questionnaire and food composition table. Folates in red blood cells (EF) were measured by a microbiological assay and plasma homocysteine (pHCY) by HPLC. MTHFR polymorphism was assessed by PCR.
BMI after Wt loss was 27.8 AE 3.8 kgam 2 (p`0.0001). Before Wt loss folates intakes were 270 AE 102 mgad. Folate density in food was positively correlated to EF (p`0.0006) and negatively to pHCY (p`0.003). 10% of the subjects are homozygote for the mutation (TT ), 47 are heterozygote (CT) and 44% have the wild type (CC). During Wt loss EF increase by 9% (p`0.04) and pHCY by 19% (p`0.001). pHCY increase is higher in CT ( 27%, p`0.001, n 35) than in CC ( 15%, p`0.05, n 32). In TT, neither pHCY (9.06 AE 2.46 mmolal, n 6) nor EF (207 AE 65 mgal) vary. They remain higher than in CT and CC subjects.
Daily folates intakes above 400 mgad seem to be required to prevent a rise in pHCY in severely obese adolescents during Wt reduction. The increase required is proportional to the degree of the mutation (TT b CF b CC).
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Potential hypothalamic effects of leptin in cafeteria diet-induced hypertension Obesity is the most common cause of hypertension. Recent observations suggest that leptin and its multiple interactions with neuropeptides in the hypothalamus may link excess weight gain with increased sympathetic activity and elevated blood pressure. In hypothalamus of cafeteria-fed rats, a model of obesity-induced hypertension, we studied leptin receptor, neuropeptides and adrenergic system. After 10 weeks of diet, hyperleptinemia was associated with a decrease in leptin receptor mRNA (735 and 745% for the short and the long isoform respectively). Leptin receptor belongs to cytokine receptor, we therefore ewamined inhibitors of cytokine signaling. Expressions of CIS and SOCS-3, known modulators of leptin signaling, were unchanged but SOCS-1 was surprisingly increased. The leptin effect on SOCS-1 increase and its role in the hypothalamic leptin signaling during obesity remain to be determined. A decrease in proopiomelanocortin (POMC) gene expression was also observed without modi®cation in neuropeptide Y mRNA. The decrease in leptin receptor could participate to the state of leptin resistance observed in obesity and contribute to decrease POMC. POMC down-regulation in cafeteria-fed rats could contribute to the onset of hypertension by a decrease in the hypotensive action of b-endorphin, a POMC product, or by conversion of this hypotensive response to a contrasting pressor response to b-endorphin previously observed in obese rats. On the other band, tyrosine hydroxylase (TH), the rate limiting enzyme in catecholamine synthesis, and a 2B -adrenoceptor were up-regulated. These modi®cations suggest an elevation in sympathetic activity and may participate to elavated blood pressure. If leptin has been shown to increase TH mRNA levels in culture porcine adrenal medullary chromaf®n cells, the leptin involment in the overexpression of TH mRNA in the hypothalamus of cafetria-fed rats remains to be determined.
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Blood pressure in relation to birth weight and weight history during childhood and adulthood in Danish men ) and 236 random controls were identi®ed retrospectively from draft board examination medical records. Weight and height during childhood (7 ± 13 years of age) were available from school health records in which birth weight, based on mothers recall when the child attended school, was also reported. The subjects were invited to participate in two follow up studies (median age 36 years (interval 25; 53 years) and 47 (interval 37; 64 years), respectively), where height, weight and blood pressure were measured. By multiple regression the importance of BMI and change in BMI in childhood and adolescence for blood pressure as adults after taking current weight and age into account was estimated. RESULTS: Current BMI and age were positively associated with systolic and diastolic blood pressure. While taking these effects into account, BMI during childhood, or change in BMI in childhood or adolescence, had no in¯uence on blood pressure. Birth weight was negatively related to systolic blood pressure (regression coef®cient 72.0 mmHg per kg; 95% con®dence interval 74.0; 70.1 and 72.7 mmHg per kg; 95% con®dence interval 75.3; 0.0 at ®rst and second follow up, respectively), when adjusting for current BMI and age. Further adjustments for BMI measurements in childhood or adolescence did not change these estimates. CONCLUSION: Obesity increases the risk of hypertension, but the duration of obesity seems not to have an additional in¯uence on blood pressure. This has implications for the understanding of the relation between obesity and blood pressure. However, birth weight was negatively related to blood pressure, only after taking current BMI into account, indicating an adverse effect of a catchup in weight. Since BMI measurements from the age of 7 years and change in BMI in childhood and adolescence had no in¯uence on blood pressure, this catch-up in weight has probably taken place before the age of seven.
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Obesity reduces muscle metabore¯ex control (MVC) . RESULTS: Baseline MSNA (38 AE 2 vs 31AE 1 burstsamin, P 0.001) and mean blood pressure (MBP, 100 AE 2 vs 91AE 3 mmHg, P 0.0036) were higher in OW compared with LW. FBF was lower (1.90 AE 0.07 vs 2.27 AE 0.15 mLamina 100 g, P 0.02), while forearm vascular resistance (FVR) was higher in OW (57 AE 3 vs 45AE 3 units, P 0.03). During 10% MVC, MSNA increased similarly in both groups, but during 30% MVC, MSNA increased was higher in LW. The responses of FBF and FVR during both 10 and 30% MVC were similar between groups. During post-handgrip circulatory arrest, MSNA remained signi®cantly elevated compared with baseline in both groups, but this increase was signi®cantly lower in OW compared with LW (3.8 AE 0.82 vs 9.4 AE 1.03 burstsamin, P 0.002). Further analysis showed the same results when we compared a subset group 17 OW with similar MBP levels than LW. . RESULTS: Our LV observations con®rm previous ®ndings. Short axis measurements of the LV showed larger cavity size (LVEDD 5.2 AE 0.6 vs 4.3 AE 0.6 cm), increased wall thickness (1.3 AE 0.1 vs 1.0 AE 0.1 cm) and greater LV mass (LV massaheight index 206 AE 52 vs 96 AE 19 gam, p`0.01 for all) in obese vs controls. LV systolic excursion (SE) and shortening rate (SR) were no different to controls, but lengthening rate (LR) was reduced (8.3 AE 2.6 vs 10 AE 2.5 cmas), trans-mitral a wave was greater (0.7 AE 0.1 vs 0.5 AE 0.1 mas) and eaa ratio was reduced (1.1 AE 0.3 vs 1.4 AE 0.4) in obese vs controls. (p`0.05 for all). We report for the ®rst time alterations in RV function. RV SE and SR were similar in the obese (2.4 AE 0.3 vs 2.5 AE 0.3 cm, 11.2 AE 2.4 vs 10 AE 2.5 cmas p ns). But LR was reduced in the obese vs controls (8.4 AE 2.4 vs 10 AE 2.5 cmas, p`0.05). Trans-tricuspid a wave was greater (0.5 AE 0.1 vs 0.2 AE 0.1 mas), eaa ratio was reduced (0.9 AE 0.2 vs 1.9 AE 0.4), while RV isovolumic relaxation time increased, in obese vs control. (73 AE 22 vs 40 AE 15 s, p`0.0l for all). PA pressure was similar in obese and controls (20 AE 5 vs 18AE 6 mmHg). CONCLUSIONS: Extreme obesity is characterised by alterations in LV and RV diastolic function. In addition, there are signi®cant alterations in LV mass and cavity size. These changes contribute to the increased risk of cardiovascular morbidity and mortality in obese subjects.
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Sibutramine improves clinical and metabolic parameters in obese patients with polycystic ovary syndrome 
METHODS:
Group-1 patients (n 14) were treated with EE-CPA alone, group-2 patients (n 12) with sibutramine alone (l0 mgad) and group-3 patients (n 14) with EE-CPA plus sibutramine combination. All three groups of patients were advised to consume a diet of 1200 kcalad. Body mass index (BMI), waist to hip ratio (WHR), systolic blood pressure (sBP), diastolic blood Track 6 Cardiovascular system and obesity S77 pressure (dBP), Ferriman-Gallwey hirsutism score (FG), serum levels of total testosterone (TT), free testosterone (FT), SHBG, DHEAS, total cholesterol (TC), HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), triglyceride, glucose and insulin during OGTT, insulin sensitivity index obtained from OGTT (ISIcomposite), area under the curve for glucose (AUC-glucose) and insulin (AUC-insulin) were measured before and after 6 months of the treatment. RESULTS: BMI, FG, serum TT, FT and DHEAS levels signi®cantly decreased and SHBG signi®cantly increased at the end of the study in all groups. WHIR, dBP and serum triglyceride level signi®cantly reduced only in group-2. Both group-2 and group-3 patients had signi®cantly reduction in the levels of AUC-glucose, AUC-insulin and ISI-composite. Group-1 and group-3 patients showed signi®cantly increase in the serum level of HDL-C. Serum triglyceride level signi®cantly increased only in group-1 patients. CONCLUSION: This study has showed that treatment with the weight losing drug sibutramine may improve hyperandrogenemia, and clinical and metabolic risk factors for cardiovascular disease in obese patients with PCOS. Sibutramine combination with EE-CPA may also enhance effectiveness in the treatment of hirsutism, and further decrease cardiovascular risk by increasing serum HDL-C level.
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The percentage of body fat and its relationship to age and blood pressure in men and women without cardiovascular medication 2 ) without cardiovascular medication at a medical outdoor center. Beside laboratory controls, blood pressure measurements and calculation of the body mass index (BMI), the percentage of body fat was determined by a method of bioimpedance applying the OMRON BF 302 body fat monitor. Patients were assigned to a group with normal percentage of body fat (24% and less in women; 19% and less in men) and to a group with a more pronounced percentage of body fat (25% and more in women; 20% and more in men). RESULTS: The mean age of women in the group with a lower body fat content (14.5 AE 4.5%) was 43.4 AE 17.7 years, and thus signi®cantly younger than in the group with a more pronounced body fat content (30.6 AE 6.9%) with a mean age of 64.1 AE 12.7 years (p`0.021). Blood pressure values were signi®cantly lower in the leaner group (125.0 AE 23.3 mm Hg and 78.9 AE 12.6 mm Hg) than in the group with an increased body fat content (144.5 AE 16.6 mm Hg and 88.0 AE 14.1 mm Hg) (p`0.050). The results in the male group were in accordance to the ®ndings obtained in women. Men with a lower percentage of body fat (15.2 AE 3.4%) were younger (52.7 AE 17.4 years) and revealed lower blood pressure values (130 AE 19.2 mm Hg and 79.7 AE 8.8 mm Hg) than men with a more pronounced percentage of body fat (25.7 AE 4.0%) with a mean age of 63.8 AE 12.7 years (146.4 AE 23.5 mm Hg and 90.7 AE 11.8 mm Hg). Systolic as well as diastolic blood pressure values showed a strong positive correlation with the percentage of body fat in men (R 0.35; p`0.033) and women (R 0.44; p`0.015). CONCLUSIONS: Our results suggest that age and blood pressure values are related to the percentage of body fat content also in non-obese patients without cardiovascular medication. An increase in the incidence of atherosclerotic cardiovascular disease is observed in women after menopause. An increase in intraabdominal fat and a more atherogenic lipid pro®le might-in part-be operative for this observation.The aim of this study is to determine the body fat distribution and cardiovascular risk factors in pre-and post menopausal obese women matched for weight, height and body mass index (BMI Hypertension is a common disorder associated with obesity and Type II diabetes. The reninangiotensin system (RAS) is important for the regulation of blood pressure and previous studies have demonstrated the presence of the components of an active tissue RAS in human adipose tissue. In this study we investigated the in¯uence of varying insulin doses on both the expression of angiotensinogen and the secretion of angiotensin II in human subcutaneous (Sc) abdominal fat.
Isolated Sc adipocytes (n 10) were treated with varying doses of insulin (1 nM ± 1000 nM) for 48 hrs. Following treatment, the media from the adipocytes and the adipocytes were harvested. Western blotting was performed on the protein extracted from the adipocytes to determine angiotensinogen expression. ELISAs were performed on the collected media to determine the secretion of angiotensin II from human adipocytes. Angiotensinogen mRNA levels were also assessed.
Our results demonstrate that increasing doses of insulin (Ins) raised angiotensinogen protein expression in a dose dependent manner (control 1.0 AE 0.0; (mean AE SE), protein expression measured relative to control; 1 nM Ins: 1.13 AE 0.1; l0 nM Ins: 1.37 AE 0.14:*; l00 nM Ins: 2.1 AE 0.3:**; 500 nM Ins: 4.1 AE 0.83:**; l000 nM Ins: 5.2 AE 8.7:**; *p`0.05, **p`0.01). Insulin also raised angiotensin II secretion in a similar pattern to angiotensinogen protein expression (control: 155 AE (SEM) 6.4 pgaml 1 nM Ins: 98 AE 3.6 pgaml;***; l0 nM Ins: 181 AE 2.5 pgaml:**; l00 nM Ins: 216 AE 8.7 pgaml:***; 500 nM Ins: 687.3 AE 11.7 pgaml***; 1000 nM Ins: 1964 AE 18.2 pgaml***:; ***p`0.001).
In conclusion, increasing insulin doses stimulate both angiotensinogen and angiotensin II production in adipocytes showing active regulation of the renin-angiotensin system in fat by insulin. This insulin regulated, adipose tissue-derived angiotensin may be important for obesity related hypertension.
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LDL phenotype B and triglyceride rich lipoproteins in overweight patients related to platelet adhesion
Department of Clinical Biochemistry, Collegium Medicum, Jagiellonian University, Krakow, Kopernika 15A str., Poland
INTRODUCTION:
The genetically determined and environmentally in¯u-enced LDL pattern B (atherogenic lipid pro®le ALP) and triglyceride rich lipoproteins have recently been recognised as an important risk factor of CAD. The nongenetic factors shown to in¯uence LDL density include intraabdominal fat accumulation, exercise and diet. Blood platelet adhesion contributes to pathomechanism of atherosclerosis. The aim of the study was to determine the in¯uence of lipoprotein composition on platelet adhesion in relation to obesity. METHODS: Lipoproteins (VLDL, LDL, HDL) were isolated from fasting plasma of overweight subjects (BMI b 25 kgam 2 ). VLDL after standard fat meal were also used. The particle distribution pro®le (LDL, HDL), apoE phenotype, a Track 6 Cardiovascular system and obesity S78 tocopherol and b carotene contents, susceptibility to oxidation and reactive lysine amino groups (R-Lys) were estimated. Adhesion of human washed platelets to native and oxidized lipoproteins immobilized in microtiter wells was examined. The total number of adhered platelets was measured as the platelet acid phosphatase activity. RESULTS: Platelet adhesion was activated by all the lipoproteins tested. VLDL, small dense LDL and oxidized lipoproteins were the most potent adhesion activators. Platelet adhesion to VLDL was in¯uenced by apoE phenotype and R-Lys content. The standard fat meal augmented platelet adhesion to VLDL. Adhesion to LDL and HDL was related to antioxidant content, particle density, oxidative susceptibility and R-Lys level. High antioxidant content in LDL and HDL strongly limited platelet activation. Enrichment of LDL and oxLDL in oxidatively modi®ed lipids: 7-ketocholesterol and lyso-PC increased platelet adhesion. BMI correlated with platelet adhesion to VLDL (r 0.55, p.`0.05) and to dense LDL (r 0.48, p.`0.05). CONCLUSION: Particle distribution pro®le, apoE phenotype and antioxidant contents strongly in¯uenced platelet adhesion to lipoproteins in overweight patients. Fasting and postprandial VLDL, small, dense LDL, native antioxidantpoor and oxidized lipoproteins were the most potent adhesion activators. 
Obesity is associated with an increased incidence of hypertension, unexplained death, as well as an overall increase in mortality rate. The autonomic nervous system is involved in the regulation of energy metabolism and cardiovascular system activity. Obese persons often have an alteration in their autonomic nervous system, accounting for several clinical consequences of obesity. Silent myocardial infarction and myocardial ischemia seem to be associated with cardiac neuropathy in some cases. Long before the appearance of clinical signs of autonomic neuropathy, subclinical signs can be detected. It has been suggested that subclinical signs of cardiovascular autonomic neuropathy appear in obese children and adolescents. METHODS: To evaluate the alterations in cardiac autonomic function, subclinical signs of autonomic neuropathy were investigated in 47 obese children (age: 13.4 AE 2.53 years, body weight: 81.64 AE 16.3 kg, body fat: 32.9 AE 8.1 kg [mean AE SD]) with different cardiovascular risk factors. Resting heart rate, heart rate variation to deep breathing, heart rate response to standing from a lying position, fall in systolic blood pressure on standing, and rise in diastolic blood pressure during sustained handgrip were measured, by means of standardized tests. RESULTS: Using reference ranges obtained in normal weight controls (Barkai et al, Arch Dis Child 1995; 73: 515 ± 518), 19 obese children (40%) had 2 or more abnormal autonomic test results (Table) . CONCLUSION: Cardiovascular autonomic dysfunctions are detectable in obese children. According to the preliminary results further investigations are needed to clarify subgroups being at risk of autonomic dysfunctions.
P173
Is the reduction of coronary heart disease risk by sibutramine dose-related?
KW Lauterbach
1
, and T Evers 
INTRODUCTION:
The additive nature and direct relationship between independent risk factors and the probability of CHD is well established. On the basis of these risk factors equations have been developed which allow to predict the probability of a CHD within a speci®ed time frame. As recent results indicated that sibutramine signi®cantly reduces the probability of a CHD within 10 years we investigated whether this reduction is dose-related. METHODS: We applied the Whitehead and Whitehead meta-analysis technique and the Framingham risk equation on data from 5612 patients from 26 studies. We compared patients receiving 10 mg or 15 mg sibutramine once daily with all placebo patients. RESULTS: Treatment difference in 10-year CHD-risk change 1 1 sibutramine minus placebo; Whitehead and Whitehead meta-analysis technique; sibutramine categorical analysis vs all placebo.
CONCLUSION:
The results indicate that sibutramine signi®cantly reduces the risk of CHD in a dose-dependent manner. ' (i.e., rWEp and rWAp) are calculated by dividing the MNV by the value measured in the person studied. In normal subjects WE 7 WA is always close to 1, with maximal variations between 0 and 2. The MNV of WE and WA needs not be strictly de®ned or related to sex or groups. Rather, à`g eneral mean normal value'' can be selected, leaving sex or group variations to be re¯ected by small variations of the WE 7 WA obtained. We selected as mean normal values 70 (Kg) for WE and 80 (cm) for WA. We studied 95 subjects (25 male and 70 female), age 18 ± 71 years, BMI 24.07 ± 52.76 and WaH 0.76 ± 1.13, and analyzed the correlations with several risk factors. RESULTS: In our study population, WE 7 WA ranged from 0.86 to 1.50, and was signi®cantly correlated with an index of insulin sensitivity deduced from the OGTT data, triglycerides, uric acid and diastolic blood pressure (r 0.40 7 0.45, p`0.001 in all instances). BMI and WaH (as well as the combination of 3 or all the 4 anthropometric measures mentioned above) showed only 3 of these correlations with weaker``r'' and``p'' values. CONCLUSION: WE 7 WA seems as a promising risk index in obese patients.
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Increased arterial pulse pressure in subjects with moderate obesity but not in those with simple overweight 
INTRODUCTION:
The study aimed at comparing the changes in mean arterial pressure (PAM) and pulse pressure (PP) in obese, overweight and lean subjects submitted to an orthostatic test (``squatting'') and continuous cardiovascular monitoring.
Track 6 Cardiovascular system and obesity
S79
International Journal of Obesity METHODS: 30 obese subjects (BMI: 33.5 AE 2.6 kgam 2 ± mean AE SD ± ), 30 overweight individuals (BMI: 26.7 AE 1.4 kgam 2 ) and 30 lean controls (BMI: 22.2 AE 1.6 kgam 2 ) were submitted to an active orthostatic test (1 min standing ± 1 min squatting ± 1 min standing). The three groups were matched for sex (11 women and 19 men) and age (around 42 years), and no subjects took medication interfering with cardiovascular regulation. Systolic, diastolic, mean and pulse arterial blood pressure were continuously monitored with a Finapres R device (Ohmeda, USA). RESULTS: PAM (p 0.06) and heart rate (p 0.08) tended to be higher in obese vs lean subjects when averaged during the whole test. During squatting, PAM was higher in obese subjects (95.7 AE 13.6 vs 84.9 AE 16.0 mm Hg, p 0.007) while it was intermediate in overweight subjects (92.9 AE 15.8 mm Hg, p 0.06 vs lean; NS vs obese). Heart rate during squatting was higher in overweight (85 AE 14 beatsamin; p 0.005) and in obese (83 AE 13 beatsamin; p 0.035) subjects than in lean controls (76 AE 9 beatsamin). Average PP was similar in overweight and lean subjects (46.4 AE 15.8 vs 45.7 AE 10.6 mm Hg, NS), whereas it was markedly increased in obese subjects (53.8 AE 12.2 mm Hg, p 0.009 vs controls and p`0.05 vs overweight subjects). Such a difference was observed throughout the test and in each posture condition (standing or squatting). CONCLUSION: Increased heart rate, mean arterial pressure and pulse pressure levels were observed in obese middle-aged subjects. Because high pulse pressure has been shown to be associated with a higher risk, such an increase may contribute to the higher cardiovascular rnortality of obese patients.
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Low-fat, high-carbohydrate diets do not inevitably lead to hrypertriglyceridaemia INTRODUCTION: Low-fat diets are established as the best way to lose weight and maintain weight loss. Reducing dietary fat usually leads to an increase in the carbohydrate (CHO). Recently, concern has been expressed that these low-fat, high-CHO diets cause hypertriglyceridaemia (HTG), a known risk factor for coronary heart disease. The objective of this study was to discover if the type of carbohydrate consumed had any effect on the degree of HTG observed. METHODS: Five normal-weight, normolipaemic subjects (3 female, 2 male) were recruited. Each followed 3 different 3-day, isoenergetic, weight maintenance diets. Each diet was separated by at least one month. These consisted of one high-fat diet (50% fat, 35% CHO, 15% protein), a`high-sugar' diet (70% CHO, 40% as sucrose, 30% as complex-CHO, 15% fat, 15% protein), and a`high-starch' diet (70% CHO, 40% as complex-CHO, 30% as sucrose, 15% fat, 15% protein). Each diet was followed by a study-day, where fasting and postprandial triacylglycerol (TG) concentrations were measured. Subjects all received an identical mixed-meal. RESULTS: There was a signi®cant effect of diet on fasting TG (p`0.0001 by repeated measures ANOVA). Post-hoc tests with Bonferroni correction showed that fasting TG was signi®cantly higher after the high-sugar diet compared with the high-fat (p`0.005) and high-starch diet (p`0.008). There was no signi®cant difference between fasting TG concentration on the high-starch compared to the high-fat diet. The high-sugar diet signi®cantly increased plasma TG compared with the high-starch diet (p`0.03) and high-fat diet (p`0.05). However, there was no signi®cant difference between TG concentrations on the high starch compared with the high-fat diet. CONCLUSION: A low-fat diet need not result in increased fasting and postprandial TG concentrations if dietary fat is replaced with complex carbohydrate rather than sugar.
KS Culling
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Improvement of cardio-vascular risk factors with a six months orlistat treatment in overweight and obese patients with comorbidities B Guy-Grand 1 , H Gin 1 , P Drouin 1 , E Eschwege 1 , and P Valensi A six month multicenter double blind study was conducted in 1004 overweight and obese outpatients with comorbidities (18 ± 65 y., BMI 28 ± 40 Kgam 2 ): 197 patients with hypercholesterolemia (LDL-C 3.4 ± 5.8 mM), 193 with type 2 diabetes (HbA1c 7 ± 9%), 614 with hypertension (Diastolic BP 90 ± 110 mmHg). Patients had to be stable on therapy for their comorbidities for at least 3 months prior to inclusion and during the study. Patients were randomized to orlistat 120 mg t.i.d. (O) or placebo (P) combined with a mildly reduced-calorie and fat diet.
At baseline there were no signi®cant difference between O and P. The variations of the primary endpoints are shown below:
In hypertensive patients, DBP changes (77.5 AE 10.6 mmHg) did not differ in O and P. In diabetics, HbA1c levels decreased ! 1% in 34% vs 21% and ! 1.5% in 19% vs 4% of O and P patients respectively (p`0.005). In hypercholesterolemics, LDL-C levels decreased ! 20% in 31% and 13% of O and P patients (p`0.005).
These results show that orlistat treatment in overweight and obese patients with comorbidities is able to further improve cardiovascular risk factors, especially in those with type 2 diabetes and hypercholesterolemia.
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Effects of one year weight loss obtained by laparoscopic gastric banding on QTc interval and QT dispersion in morbid obesity 2 ) underwent laparoscopic gastric banding (LAGB) and received low calorie diet (900 ± 1100 Kcaladay) for one year. QT intervals were measured on 12-lead resting electrocardiograms and were adjusted for heart rate according to Bazett's formula. QTd was expressed as the difference between the maximum and the minimum QTc in any of the 12 electrocardiographic leads. Patients using drugs known to affect QTc interval or patients with heart diseases were excluded. RESULTS: BMI dropped to 36.4 AE 0.55 Kgam 2 (p`0.001); QTc changed from 412.5 AE 2.67 ms to 399.2 AE 2.77 (p`0.001) and QTd from 37.9 AE 3.8 to 35.3 AE 1.6 ms (p`0.001). CONCLUSION: These data indicate that a signi®cant weight loss is accompanied by a signi®cant decrease of both QTc and QTd. REFERENCES: 1) Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J``QTc prolongation measured by standard 12 lead electrocardiogram is an indipendent risk factor for sudden death due to cardiac arrest'' Circulation 83: 1888 ± 1894, 1991 2) Sagie A, Larson MG, Goldberg RJ, Bemgston JR, Levy D``An improved method for adjusting the QT interval for heart rate (The Framingham Heart Study)'' Arn J Cardiol 70: 797 ± 801, 1992 3) Seim HC, Mitchell JE, Pomeroy C, De Zwaan M,``Electrocardiographic ®ndings associated with very low calorie dieting'' Int J Obes 19: 817 ± 819, 1995 4) Carella MJ, Mantz SL, Rovner DR, Willis PW, Gossain VV, Bouknight RR, Ferenchick GS``Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss'' Int J Obes 20: 938 ± 942, 1996
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Tilt 2 ) ± group C. Additionally TT was performed in 11 pts from group A after 3-months of weight reducing treatment. The cardiovascular reactions to tilting were determined by the measurements of HR, SBP and DBP. We assessed: baseline values, values after tilting, difference between maximal and minimal values during TT (A), and index of change (%D Dabaseline value Â 100%). RESULTS: Positive TT was observed in 10 obese pts (17%), and none of the controls. The comparison of HR, SBP and DBP between groups A and C revealed higher DHR in group of obese pts (23.9 AE 13.7 vs 17.87 AE 8.9) only. In pts with positive TT results signi®cant higher HR after tilting, DHR, and %DHR were noted in comparison to pts with negative TT and to group C. Pts after weight reducing treatment were characterised by: higher %DHR than group A, and lower baseline HR, SBP, DBP in comparison both to group A and to their results before treatment. CONCLUSION: The positive results of TT are observed in 17% pts with simplex obesity. Different HR reaction to tilting (increased HR¯uctuation) is present in obese pts, especially in pts with positive TT. The 3-months weight reducing treatment decreases HR, SBP and DBP, but does not normalize the cardiovascular reaction to tilting. Our results can support the hypothesis of autonomic disbalance in obesity. Supported by KBN grant C008aP05a2000 Plasma homocysteine (Hcy) is a risk factor for cardiovascular disease and is thought to be increased by a high protein intake. We studied the effect of protein intake in obese subjects in a 6 mo randomized intervention study comparing two ad lib fat reduced diets (30% of total energy): Low-protein (LP, 12 energy-%) or high-protein (HP, 22 energy-%). 65 overweight and obese subjects were randomly assigned to LP (n 25), HP (n 25) or a control group (C, n 15). All food was provided by self selection in a shop at the department. Compliance to the diet composition was evaluated by urinary nitrogen excretion.The protein intake was increased in the HP group mainly by lean meat and low fat dairy products. Folate intake nearly doubled in the LP group and increased by 60% in the HP group (LP vs HP; P`0.05). It remained unchanged in the C group (LP & HP vs C; P 0.0001). B 12 intake decreased in the LP and increased by 80% in the HP (P`0.0001), whereas B 6 intake increased by 70 ± 90% in LP and HP groups with no change in the C group (P`0.0001). Plasma Hcy did not change in the LP or C groups, but there was a non-signi®cant 20% decrease in the HP group. Fat loss was 4.3 kg in LP and 7.6 kg in HP (P`0.0001), with no change in the C group. In multiple linear regression analyses plasma Hcy after 3 mo intervention was determined by baseline Hcy (r 0.34, P 0.0001), folate intake (r 70.003, P 0.0350), dietary protein content (r 70.17, P 0.0007), and by weight change (r 70.12, P 0.0350). After 6 mo the same trends were seen (baseline Hcy P 0.0001; protein content P 0.09). This study shows that increasing the dietary protein from 12 to 22 energy-% does not increase plasma homocysteine levels. By contrast, animal protein, independent of intake of B vitamins and weight loss, may actually decrease plasma homocysteine concentrations in obese subjects. METHODS: Pooled data of two randomized, parallel groups, double blinded, multicenter clinical trials. 514 patients with BMI ! 27 kgam 2 were randomized (261 Orlistat, 253 placebo) after 4 weeks of placebo run-in and hypocaloric diet (30% of calories from fat). Cardiovascular risk at 10 years was computed using Framingham algorithm assuming all patients were smokers. RESULTS: Baseline cardiovascular risk was similar for Orlistat (ORL) and placebo (PLA) (14.45% vs 13.36%). The change in predicted 10-year cardiovascular risk after 6 months treatment was threefold for Orlistat than for placebo (71.43% vs 70.53%, p 0.063). Greater risk reduction was observed among hypercolesterolemic patients (73.02%) than diabetic patients (71.46%). Signi®cant mean weight loss was achieved with Orlistat when pooling data from diabetic and non diabetic patients (77.1% vs 73.46%, p`0.001). Diabetic mellitus group lost less weight than non diabetic mellitus, consistent with previous reports than weight loss is more dif®cult for DM. Orlistat achieved a higher reduction of mean waist perimeter (76.36 vs 74.2 cm, p`0.001) and BMI (72.66 vs 71.37, p`0.001). 31.5% and 38.3% of patients normalized total cholesterol and LDL cholesterol, respectively with ORL in comparison with 22.5% and 26.1% with placebo (p 0.018 and p 0.003). Greater reduction of plasma glucose was achieved with ORL than with placebo (1.59 vs 0.79, p`0.001). CONCLUSION: Orlistat produces a signi®cant weight loss as well as a reduction of cardiovascular risk through decreases of total and LDL cholesterol and an improvement of metabolic control of type 2 diabetes in overweight or obese patients with additional risk factors.
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Sex hormone ± binding globulin levels and cardiovascular risk in morbidly obese subjects before and after diet or biliopancreatic diversion Several studies showed that in obese subjects low plasma SHBG levels were associated with high fasting insulin concentrations and with an altered lipidlipoprotein pro®le, including reduced HDL cholesterol and an increased atherogenic index. A cross-sectional study was conducted to verify the changes of SHBG and lipid pro®le in 79 morbidly obese subjects, 27 men and 52 women (age: 30 ± 45yrs), randomly assigned to the diet protocol (20 kcalakg FFM , 55% carbohydrates, 30% fat, and 15% proteins) or to BPD procedure. We investigated the modi®cation of Coronary Heart Disease (CHD) risk in morbidly obese subjects after weight reduction treatment, either diet or biliopancreatic diversion (BPD), and to evaluate whether SHBG changes might play any pathogenetic or diagnostic role.
Fatness parameters by dual-energy X-ray absorptiometry (Fat Mass and Fat-Free Mass), SHBG and sex hormones plasma levels and lipid pro®le at baseline and 1 year after the beginning of the study has been evaluated.
Pre-Post weight loss differences in SHBG plasma levels were signi®cantly higher in the BPD group compared to the dieting group (84.0 AE 25.2 nMal vs 143.4 AE 23.4, P`0.0001). Furthermore, surgical treated subjects largest changes in insulin, total cholesterol, HDL-cholesterol and tryglicerides after weight loss compared to the diet-group. (P`0.0001). The main result was the signi®cant decrease of the atherogenic risk observed in BPD patients (6.58 AE 3.33 vs 2.90 AE 0.58 after the treatment; P`0.0001), while no differences were found in dieting patients.
A step-down regression analysis showed that FFM and SHBG were the most powerful independent variables for predicting HDL-cholesterol levels; while insulin did not in¯uence signi®cantly HDL-CH changes. The positive relationship between low SHBG levels and increased CHD risk appears to be mediated, to a large extent, by concomitant variation in body fatness measured directly. In this regard, SHBG level may be viewed as a re¯ection of total adiposity rather than a predictor of an altered insulinaglucose homeostasis.
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Autonomic nervous system activity in obese subjects and during weight reduction Power spectral analysis of heart rate variability during modi®ed orthostatic test is the non-invasive method used for the evaluation of autonomic nervous system (NS) activity.
In the groups of 82 healthy volunteers (BMI 24.9 AE 2.7 kgam 2 ) and 37 healthy obese subjects (BMI 36.1 AE 4.9 kgam 2 ) some of the vegetative NS parameters have been compared. In the group of 16 volunteers we measured the vegetative NS activity changes during the weight reduction regimen (10 day's hospitalisation, daily energy intake 3300 kJ, weight before 101.5 AE 18.1 kg, after 97.5 AE 17.1 kg, p`0.0001). Acute reactions to the energy restriction were evaluated in the groups of 10 volunteers during 3 days of energy intake 3200, 6600 a 13 400 kJ.
Obese persons show a slight decrease of both sympathetic and parasympathetic NS activities. In the supine position, only few changes in the sympatheticaparasympathetic NS activity ratio were observed. In the standing position, in the obese group, a decrease of sympatheticaparasympathetic NS activity ratio was described. Signi®cant correlations between sympathetic NS activity and lipid oxidation (r 0.329, p`0.01) as well as saccharide oxidation (r 70.258, p`0.05) were observed.
During the weight reduction, a slight increase of the parasympathetic NS activity and a higher increase in the sympathetic NS activity were measured. Acute reaction to the low-energy diet was observed in a few days. Relative increase mainly in the sympathetic NS activity doesn't depend on the degree of energy de®ciency only, but some subjective factors may play a signi®cant role.
In the group of obese persons non-speci®c changes of the vegetative NS activity were observed. They are modulated by some behavioural factors. The tendency to the higher parasympathetic NS activity con®rms the MONA LISA theory of the origin of obesity. The return of the indexes after overweight reduction is an important information. The purpose of this study was to assess left ventricular (LV) structure, systolic and diastolic function in obese children. The study group consist of 25 young patients (aged 12 ± 17) with body mass index (BMI) above 30 kgam 2 . The results were compared with those in a control group of 15 healthy children without overweight.
Echocardiography was performed and echocardiographic measurements were obtained in accordance with the recommendations of the American Society of Echocardiography with the exception of data for LV mass, which was derived using Penn convention methodology. LV diastolic ®lling was assessed using pulsed-wave Doppler echocardiography, in accordance with the methods of Nishimura at all.
It was established that LV mass, LV mass corrected for body surface and LV mass corrected for height were signi®cantly higher in obese children. The prevalence of LV hypertrophy in children with obesity (using LV massaheight index) was almost 78%.
The tested parameters of the left ventricle systolic function: shortening fraction (%SF), ejection fraction (%EF) were within normal values and there were no signi®cant differences when compared to controls with normal weight. The date obtained from pulsed ± Doppler echocardiography indicate that left ventricular ®lling pattern in obese children also was no signi®cantly disturb. Peak early (MVE) left ventricular ®lling velocity, peak atrial (MVA) velocity, MVEaMVA velocities ratio were similiar in both groups.
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MUFA enriched hypocaloric diet: effect on weight loss and on atherosclerosis In 23 obese patients, we compared the effects of 2 hypocaloric diets (730% of total energy expenditure) on weight loss rate, on smooth muscular cell (SMC) proliferation and on blood cardiovascular risk factors : TG, TC, HDLc, LDLc, ®brinogen, Lp(a), insulin resistance (HOMA). In % of total energy intakes, the composition of the 2 diets (proteinsafatsaCHO) was 20a25a55 (diet A, n 11) vs 20a40a40 (diet B, n 12). 65% of total energy intake was brought by CHO and MUFA in both diets: 55 10 (diet A) and 40 25 (diet B enriched in olive oil). Biology was evaluated at days 0 and 60. Weight was measured at days 0, 30 and 60.
Neither at day 30 nor at day 60 was the weight loss dependent on the type of the diet. At day 60, insulin resistance and plasma concentrations of TG, TC and LDLc were signi®cantly diminished independently of the type of the diet. HDLc, Lp(a) and ®brinogen remained unchanged. SMC proliferation was enhanced with type A diet ( 3.67%, p 0.025). Changes in SMC proliferation (%) were negatively correlated to changes in HDLc (r 70.51, p 0.012) and to the compliance to the diet (r 70.48, p 0.018). In stepwise multiple regression, changes in SMC proliferation could be explained by changes in HDLc (step 1: 23%) and by compliance to the diet (step 2: 16%).
In conclusion, during the early weight loss, diets enriched in olive oil could have a protective effect on SMC proliferation and therefore on atherosclerosis.
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The effects of symptomatic and asymptomatic left ventricular systolic dysfunction on effort capacity and quality of life in 55 to 75 year olds obese patients 
D Rosu
Academic Hospital Department of Cardiology Timisoara Romania
The effects of left ventricular systolic dysfunction (LVSD) in asymptomatic form, are less known as contributor to the disabling condition in chronic heart failure.
METHODS:
We studied 69 obese patients aged 55 to 74 years, randomly selected from hospitalized patients. Cardiovascular risk factors were observed. Each patient completed questionnaires regarding medical history, the symptom of breathlessnes, quality of life, current medication. Echocardiograms and maximal exercise tests were performed. Left ventricular mass (LVM, Penn formula) and left ventricular ejection fraction (LVEF, Simpson's method) were calculated. Data was compared with the same parameters in 30 nonobese patients, with the same age and chronic heart failure. RESULTS: LVM in obese patients was 145 AE 25 gam 2 , more then 115 AE 15 gam 2 which was found in nonobese patients (p`0.01). The median LVEF was 46.7% in 7 (10%) asymptomatic obese patients and 50.9% in 5 (18%) nonobese patients (p`0.05). The median LVEF of 35%, vs 42% was found in symptomatic patients, obeses and nonobeses. The median exercise time was lower in obese then nonobese patients (302.3 s vs 380.0 s, p`0.001). Regarding asymptomatic patients, median exercise time was also lower in obese then non obese patients (324.0 s v 456.0 s p`0.001) The multivariate analysis showed that for obese and nonobese patients, LVEF was the signi®cant determinant of exercise time. In symptomatic and asymptomatic obese patients LVM was also the signi®cant determinant of exercise time. The comparison of asymptomatic obese patients with asymptomatic nonobese patients showed lower LEVF, higher LVM and also lower quality of life in obeses. CONCLUSION: The comparison between obese and nonobese patients showed a less number of asymptomatic patients with chronic heart failure, and lower quality of life between obeses. Apparently asymptomatic, obese patients presented a signi®cant decrease of LVEF. The increase of LVM in obese patients is an independent factor in the evolution of chronic heart failure. In de®ning asymptomatic cardiac heart failure, we should include the quality of life and the response to exercise tests, especially in obese pacients.
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Gender-speci®ic associations of leptin and body composition in liver cirrhosis INTRODUCTION: Data on leptin levels and their association with body composition in patients with liver cirrhosis are controversial, potentially due to ignoring gender-speci®c differences. METHODS: We therefore measured leptin, body composition (BIA) and insulin sensitivity (HOMA-Analysis) in 51 patients with liver cirrhosis (22 females (LF) and 29 males (LM)) and in 55 healthy sex, age and BM1-matched control subjects (CF, CM). RESULTS: Compared o controls, patients with liver cirrhosis exhibited decreased insulin sensitivity (l.9 AE 0.2 vs 4.4 AE 0.4, p`0.001) and increased insulin levels (50.4 AE 4.2 vs 120.0 AE 11.7 pmolaL, p`0.001). In both groups, leptin levels were increased in female vs male subjects (17.0 AE 0.3 vs 4.3 AE 0.5 ngamL, LF vs LM, p`0.001, and I3.8 AE 3.3 vs 6.4 AE 0.9 ngamL, CF vs CM, p`0.001). Leptin levels were higher (p`0.05) in male, however not in female cirrhotic patients when compared to controls. FFM was slightly reduced in LM (57.1 AE 1.9 kg vs 57.8 AE 1.2 kg, LM vs CM, p`0.05). In contrast to CM, CF and to LM patients, plasma leptin concentrations did not correlate with FM (r 0.4, p 0.08), insulin levels (r 0.2, p 0.44) or insulin sensitivity (r 0.1, p 0.65) in LF. CONCLUSION: In conclusion, only male, but not female cirrhotic patients exhibit increased leptin levels when compared to controls. Circulating leptin is not correlated to fat mass, insulin levels and insulin sensitivity in female cirrhotic patients. These data point towards a gender-speci®c difference in the regulation of circulating leptin and the association of leptin with parameters of body composition and glucose metabolism in cirrhotic patients.
P188
MUFA enriched hypocaloric diet: effect on weight loss and on atherosclerosis During hypocaloric diets, weight loss but also the dietary composition can contribute to the cardiovascular risk modi®cation. The aim of the study was to compare the effects of 2 hypocaloric diets (730% of total energy expenditure) on weight loss rate, on smooth muscular cell (SMC) proliferation and on blood cardiovascular risk factors: TG, TC, LDLc, ®brinoge Áne, Lp(a). insulinore Âsistance (HOMA). 23 obese patients were included. In % of total energy intakes, the composition of the 2 diets (proteinsafatsaCHO) was 20a25a55 (diet A, n 11) vs 20a40a40 (diet B, n 12). Monounsaturated fatty acids were 10% of calories in diet A and 25% in diet B. 65% of total energy intake was brought by CHO and monounsaturated fats in both diets: 55 10 (diet A) and 40 25 (diet B enriched in olive oil). Patients were asked to prepare their meals at home from pre-established menus, during 60 days. Biology was evaluated at days 0 and 60. Weight was measured at days 0, 30 and 60.
Neither at day 30 (74.6 kg) nor at day 60 (77 kg) was the weight loss (adjusted on mean basal weight) dependent on the type of the diet. At day 60, insulinoresistance and plasma concentrations of TG, TC and LDLc were signi®cantly diminished independently of the type of the diet. HDLc, Lp(a) and ®brinogen remained unchanged. SMC proliferation was enhanced with type B diet ( 3.6%, p 0.025). Changes in SMC proliferation (%) were negatively correlated to changes in HDLc (r 70.51, p 0.012) and to the compliance to the diet (r 70.48, p 0.018). In stepwise multiple regression, changes in SMC proliferation (%) could be explained by changes in HDLc (step 1:23%) and by compliance to the diet (step 2 : 16%).
In conclusion, during the early weight loss, neither weight loss nor lipid metabolism were dependent on dietary composition. However, during this period, diets enriched in olive oil seem to have a protective effect on SMC proliferation and therefore on atherosclerosis.
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Effects of weight loss induced by gastric surgery on blood pressure levels and metabolic parameters 2 , mostly of them with associated morbidity, as hypertension, diabetes or dislipemia, which augment their cardiovascular risk. METHODS: In this study 15 severe obese patients (12F, 3M), aged 38 AE 10 years old and BMI of 50 AE 6 kgam 2 , were submitted to gastric surgery (band by-pass) and evaluated for BMI, blood pressure (BP), fasting glucose (GLU), tryglicerides (TG) and cholesterol (CHOL) levels, before and after 6 AE 3 months. A 24 hour report of food ingestion was used to calculate the total energy consumed (TEC) after surgery. RESULTS: A reduction of 23.6 AE 6.0% (p`0.01) in BMI correlated with period after surgery. The TEC ranged from 220 to 1400 kcal with a positive correlation with the time after surgery (r 0.79; p`0.01), indicating an adaptative process. Systolic and diastolic BP (SBPaDBP) fell from 136 AE 12a78 AE 8 to 123 AE 17a71 AE 12 mm Hg (p`0.05),TG levels from 151 AE 85 to 106 AE 64 (p`0.01) GLU levels from 101 AE 19 to 93 AE 7 mgadl (p 0.06) without changes in CHOL. No correlation was found between changes in BP and changes in BMI. CONCLUSION: We concluded that the weight loss consequent to bariatric surgery is effective in reducing blood pressure and, tryglicerides levels, tending also to diminish glucose levels in severe obese patients, contributing to a decrease of the cardiovascular risk of these patients. The increase in TEC, an expected adaptative behavior, probably responsible for the weight stabilization after an year of the procedure, otherwise may compromise the results of the surgery during long term follow-up and needs further evaluation.
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Reduction of smooth muscle cell contraction by perivascular adipose tissue In earlier studies, perivascular adipose tissue was shown to in¯uence the underlying blood vessel contraction. We have pursued this intriguing notion. We measured contraction of male Sprague-Dawley rat (200 ± 300 g) aortic rings in a Schuler organ bath system. Vessels were either stripped of surrounding adipose tissue or were left intact and were incubated with several substances in¯uencing vascular contraction.
Contractile responses to KCI were not different between stripped or intact vessels. However, a signi®cant reduction of smooth muscle cell contraction to serotonin and phenylephrine was measured in intact vessels. Dose-response curves for serotonin and phenylephrine in intact vessels showed a signi®cantly rightward shift. The reduction of contraction response of intact vessels to serotonin and phenylephrine was abolished by preincubation of the vessels with glybenclamide. Application of cromakalim to stripped vessels resulted in a reduction of the contractile response to serotonin and phenylephrine. Other potassium channel blockers did not modulate the reduced response of intact vessels to serotonin or phenylephrine. Additionally, vessels with perivascular adipose tissue were either denuded of endothelium or were left intact to rule out an involvement of endothelium. No signi®cant differences were measured in endothelium-denuded or endothelium-intact vessels with perivascular adipose tissue.
We conclude that perivascular adipose tissue exhibited a signi®cant effect on rat aortic smooth muscle cell contraction. This modulation did not depend on the endothelium. We suggest that perivascular adipose tissue affects smooth muscle cell ATP-dependent potassium channels and thereby reduces serotonin or phenylephrine-evoked rat aortic smooth muscle cell contractions. has not yet been demonstrated to have cardiovascular mortality bene®ts. This study aimed to evaluate biochemical risk factors for cardiovascular disease in patients with type 2 diabetes undergoing orlistat induced weight loss. METHODS: 7 patients (6 females, 1 male) with type 2 diabetes were followed as part of an on going Lifestyle clinic. A dietician followed patients monthly and measured their body mass index (BMI) and hypoglycaemic agent requirement. After 2.5 kg initial weight loss in 4 weeks, they were started on orlistat 120 mg tds. Fasting blood samples were obtained before any weight loss and 6 months after orlistat therapy. Plasma was analysed for insulin, glucose, fasting insulin resistance index (FIRI glucose Â insulina25), total cholesterol, triglycerides, high density lipoprotein (HDL), calculated low density lipoprotein (LDL), Lp(a), HbAlc and homocysteine. RESULTS: The BMI of the patients decreased signi®cantly from 40.2 AE 3.23 kgam 2 (mean AE SEM) to 37.8 AE 3.23 kgam 2 (p`0.001). However the majority of biochemical markers did not show any signi®cant change: FIRI (4.1 AE 1.2 to 5.6 AE 1.3), total cholesterol (4.8 AE 0.15 mmolaL to 4.8 AE 0.18 mmolaL), triglycerides (1.4 AE 0.19 mmolaL to 1.5AE 0.23 mmolaL), Lp(a) (284 AE 87 mgaL to 258 AE 82 mgaL), homocysteine (8.6 AE 0.9 mmolaL to 8.4 AE 0.5 mmolaL). The only signi®cant improvements were HbAlc (8.7 AE 0.59% to 6.9 AE 0.29%, p 0.01) and LDLaHDL ratio (2.88 AE 0.3 to 2.32 AE 0.3, p 0.01) indicating a reduced cardiovascular risk. CONCLUSIONS: It was disappointing that the signi®cant weight reduction did not translate into reductions in all of the individual biochemical markers of cardiovascular risk. It could be postulated that a certain amount of weight loss needs to be achieved over a longer follow up period, before reduction of cardiovascular risk will be realised. The aim of this study was to evaluate the relationship between the supine sagittal abdominal diameter and others indicators of body fat distribution with cardiovascular (CVD) risk factors, such total cholesterol, HDL-cholesterol, triglycerides and blood pression, giving a particular attention to the gender differences. METHODS: One hundred and seventy eight obese women (BMI 34.4 AE 0.41 SE; age 41.2 AE 1.12 ES) and 49 obese men (BMI 34.7 AE 0.68 ES; age 40.9 AE 2.02 ES) were studied. In each subjects we evaluated: degree of overweight (BMI), fat distribution (waist and hip circumference and abdominal sagittal diameter by a sliding-beam abdominal calliper), body composition (bioelectric impedance measure), systolic and diastolic blood pressure, total and HDL cholesterol and tryglicerides. RESULTS: Both in women and in men, age was signi®cantly related to the decrease of height and the increase of waist circumference or of the waist to hip ratio. In women BMI was signi®cantly correlated with systolic pressure, total and HDL cholesterol and tryglicerides. On the contrary, BMI was signi®cantly related only with systolic pressure in men. In the group of obese women, but not in the one of obese men, waist circumference and the waist to hip ratio were signi®cantly related to systolic and diastolic blood pressure and blood lipid parameters. A signi®cant association was also found, in women, between abdominal sagittal diameter, measured with sliding beam abdominal calliper, and blood arterial pressure, but this relation was not pointed in the group of men; in obese men the abdominal sagittal diameter was signi®cantly related only to total cholesterol. In women there was a correlation between fat mass (FM) and fat free mass (FFM) and systolic blood pressure and cholesterol. CONCLUSION: Among the different measures of fat distribution, the sagittal abdominal diameter was very useful for the prediction of cardiovascular disease risk factors both in obese women (signi®cant relationship with systolic and diastolic blood pressure) and in obese men (signi®cant relationship with total cholesterol).
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Obesity and risk of cardiovascular disease development The Czech Republic ranks among the countries with highest prevalence of overweight and obesity. It is important to recognize obesity as a serious disorder associated with several chronic deseases. The study provides extensive information on selected anthropometncal and biochemical parameters, especially on those, which are generally used as risk indices for the origin and development of cardiovascular disease (CVD): body mass index (BMI), body fat percentage (b.fat), waist circumference (waist), serum concentrations of total cholesterol (Tchol), HDL-and LDL-cholesterol (HDL-chol, LDL-chol), triacylglyceroles (TAG) and the atherogenic index (AI). The nutritional status of a selected population ± 6267 male members of the Czech Army ± was assessed in 2000. The results of the study proved the considerable prevalence of the overweightness and obesity in the male population group that was followed: according to the calculated BMI, 52% of volunteers were estimated to be overweight and 15% to be obese. As far as lipid parameters were concerned, increased serum levels were estimated in 34% (TAG), 58% (Tchol) and 41% (LDL-chol) of volunteers. Decreased serum levels of HDL-chol were found in 17% of volunteers. An AI higher than 3,5 a.u. was calculated for 73% of all subjects in study. The study concept made it possible to reveal the relationships among the anthropometrical and biochemical parameters followed. The regression analysis results document a statistically signi®cant positive dependence among the BMI or waist values and the serum concentrations of Tchol, LDL-chol, TAG and AI. A signi®cant negative correlation was found between the HDL-chol serum concentration and the BMI or waist values.
The variance analysis results (the estimated lipid parameter values were divided into groups according to the BMI and waist categories) document a statistically signi®cant increase of serum Tchol, LDL-chol, TAG and AI in both the overweight and obese categories in comparison with the normal weight category. An AI higher than 3,5 a.u. was found in 61% of males with normal weight, in 79% of overweight males and in 90% of obese males. A statistically signi®cant decrease in comparison with the normal weight category was found in the HDL-chol serum levels of both the overweight and obesity categories. In the same way, an increase in Tchol and LDL-chol, TAG serum concentrations and AI values in higher CVD category (according to the waist circumference value: 94 ± 102 cm) and high risk CVD category (waist circumference value b 102 cm) was found in comparison with the low CVD risk category (waist circumference value`94 cm). These results showed that aplication of DEXA in clinical practice is easy, and could be a good reference technique.
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The bene®ts of very low calorie diet (VLCD) in the treatment extremely obese persons
E Stokic
1 , and T Ivkovic-Lazar
Dept. of Endocrinology, Medical Faculty H.Veljkova 1-3, 21000 Novi Sad, Yugoslavia
Obesity is associated with a number of disorders such as glucose tolerance disturbances, insulin resistance, hyperinsulinaemia, hypertension, dyslipidaemia, impaired ®brinolysis, accelerated atherosclerosis which all lead to cardiovascular disease. VLCD therefore bene®ts the individual by reducing health risks and improving the quality of life. In order to assess the in¯uence of VLCD on lipids, insulin, glucose, ®brinogen and blood pressure, we have evaluated 36 extremely obese females (age 32,06 a7 6.64 years), in whom, apart from standard measures (body weight, BMI, systolic and diastolic blood pressure), subcutaneous (SAT) and visceral adipose tissue (VAT) had been measured by ultrasound. Patients were treated with VLCD (1254 kJ) for 30 days. As for physical activities, during this period only the light walking has been practiced. At the end of the study BMI signi®cantly decreased (42.06 a77.64 to 37.58 a76.44 kgam 2 , p`0.05). VAT has been reduced signi®cantly (34.10 a73.25 to 24.78 a72.50 mm, p`0.05), while SAT has been reduced but only on the edge of signi®cance (p 0.05). The signi®cant improvement of the lipid parameters was observed: total cholesterol (Ch) (5.68 a71.02 to 4.2 a70.84 mmolal, p`0.001), triglycerides (2.25 a71.34 to 1.30 a70.59 mmolal, p`0.001), LDL-Ch (3.37 a71.23 to 2.68 a70.86 mmolal, p`0.05). The study has shown that the decrease of HDL-Ch happened on the bene®t of HDL3 subfraction. After weight reduction the level of ®brinogen and fasting insulin statistically signi®cantly decreased.
These results suggest that VLCD decreases signi®cantly body weight, mainly by reducing the VAT and improves the metabolic pro®le of extremely obese persons. Also, this treatment is associated with reducing in ®brinogen level.
Several prospective studies have shown that the selective accumulation of adipose tissue in the central or abdominal region is associated with an increased risk for development of cardiovascular diseases. The aim of this study was to asses gender differences in blood pressure (BP) in relation to body fat distribution in extreme obese patients (pts).
The study population consisted of 56 extremely obese patients with no signs of endocrine, cardiovascular and renal disease, divided according to body fat distribution to lower-body (LB) obese men (7 pts; 39 AE 4years, BMI 52 AE 14 kgam 2 ), upper-body (UB) obese men (11 pts; 36 AE 10 years, BMI 47 AE 5 kgam 2 ), LB obese women (19 pts; 33 AE 7 years; BMI 43 AE 5 kgam 2 ), and UB obese women (19 pts; 35 AE 8 years; BMI 45 AE 6 kgam 2 ). Patients underwent 21 days of very low calorie diet. Results are presented in the following Table including systolic (SBP) and diastolic (DBP) BP before and after the diet.
In conclusion, signi®cant reduction of BP (p`0.05) during very low calorie diet was observed in all groups except for DBP in LB obese women. In addition, BP was similar in both UB obese women and men, whereas both SBP and DBP was signi®cantly (p`0.05) higher in LB obese men then women.
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Is leptin affect arterial hypertension in obesity Ð in¯uence of insulin and different methods of obesity assessment 
INTRODUCTION:
Hyperinsulinemia is regarded as one of most important pathogenetic factors in obesity-related hypertension. Leptin, a peptide produced in adipocite tissue, regulates food intake and energy expenditure. It is also considered to participate in development of arterial hypertension mainly through sympathetic activation and mitogenic action. METHODS: 45 untreated obese hypertensives (group 1) aged 40.7 AE 7.5 years, BMI 35.4 AE 4.9 kgam 2 were compared to 40 obese normotensives (group 2) aged 37.9 AE 6.9 years, BMI 36.3 AE 5.8 kgam 2 . 20 lean normotensives matched for age constituted the control group. We measured systolic and diastolic blood pressure (SBP, DBP), waist to hip ratio (WHR), fasting serum insulin and leptin (by RIA). Adipocite tissue content was assessed by bioelectrical impedance. Results were analysed by multivariate analysis method.
RESULTS:
In group 1 we found signi®cantly elevated WHR values, serum leptin and insulin. In both groups leptin signi®cantly correlated positively with BMI, fat content, SBP, DBP and insulin. In group 1 after adjustment for BMI and insulin, leptin remained independent predictor of DBP, but this association disappeared after adjustment for adipocite tissue content as a measure of fatness. CONCLUSIONS: we did not con®rm direct relationship between serum leptin and arterial hypertension. Insulin, degree of obesity and fat distribution remain most important factors in¯uencing obesity-related hypertension. INTRODUCTION: Aim of the study was to investigate whether the result of the DASH study can be con®rmed by (i) using a German hypertensive population and (ii) replacing the well-controlled feeding design by allowing ad libitum intake according to dietary advices. METHODS: 53 overweight subjects from Potsdam with borderline hypertension and without medication were randomly assigned to either a combination diet low in fat and rich in dairy products, fruits and vegetables (I-group) or a habitual diet as control (C-group). During 5 weeks the subjects were provided 50% of their daily intake for free according to their dietary pattern. Single and 24 h blood pressure measurements, dietary and physical activity records, blood and urine samples and anthropometnc measurements were collected before, during and 5 weeks after the intervention period. RESULTS: No reduction of blood pressure could be observed in the I-group of our trial. No change of body weight was observed during the whole study period. CONCLUSION: Even convincing results of a controlled trial cannot be simply transferred into dietary advices for the general public. For addressing foodbased dietary guidelines to reduce the risk of hypertension it is necessary to consider carefully (i) the genetic background, (ii) the dietary and (iii) lifestyle situation of the target population. 
INTRODUCTION:
A positive correlation between resting heart rate and mortality has been observed. Weight gain increase resting heart rate and in¯uence the balance of the autonomic nervous system. METHODS: A sibling cohort of 7l (27 male and 43 femals) healthy mainly lean (BMI: 23.7 AE 4.1 (range 16.9 ± 38.8 kgam 2 ) subjects aged 29.1 AE 4.5 years, had their body composition estimated by bioimpedance and 24-hour energy expenditure (24-h EE) and heart rate (24-h HR) measured under standardised low physical activity conditions in open-circuit respiration chambers. Catecholamines and thyroid hormones assessed fasting after the stay. The day to night decrease in heart rate were also tested for differences between lean and obese. RESULTS: The variation in heart rate correlated primarily with lean body mass (r 70.35, p`0.01). The following prediction equations for 24-h HR was found by backward elimination:
24-h HR 71.7 ± 1.13 x FFM 0.15 x 24 hour EE(r 0.57, p 0.01). No difference in delta 24-h HR was found between obese and lean. CONCLUSION: On a low physical activity level lean body mass together with 24-h EE are the best predictors of 24-h HR. There was no difference in day to night drop in heart rate between lean and obese.
Track 6 Cardiovascular system and obesity S87
